Xbrane Delays Refiling Ranibizumab Biosimilar With US FDA To Late Spring

Meanwhile, European Sales To End Customers Grow

 
• By Urtė Fultinavičiūtė
  
A person climbing four levels of ladder, concept of challenges in business
(Shutterstock)

More from Strategy

More from Business